Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs.

Mastio J, Condamine T, Dominguez G, Kossenkov AV, Donthireddy L, Veglia F, Lin C, Wang F, Fu S, Zhou J, Viatour P, Lavilla-Alonso S, Polo AT, Tcyganov EN, Mulligan C Jr, Nam B, Bennett J, Masters G, Guarino M, Kumar A, Nefedova Y, Vonderheide RH, Languino LR, Abrams SI, Gabrilovich DI.

J Exp Med. 2019 Sep 2;216(9):2150-2169. doi: 10.1084/jem.20181952. Epub 2019 Jun 25.

PMID:
31239386
2.

Promotion of growth factor signaling as a critical function of β-catenin during HCC progression.

Kim E, Lisby A, Ma C, Lo N, Ehmer U, Hayer KE, Furth EE, Viatour P.

Nat Commun. 2019 Apr 23;10(1):1909. doi: 10.1038/s41467-019-09780-z.

3.

Rb family proteins enforce the homeostasis of quiescent hematopoietic stem cells by repressing Socs3 expression.

Kim E, Cheng Y, Bolton-Gillespie E, Cai X, Ma C, Tarangelo A, Le L, Jambhekar M, Raman P, Hayer KE, Wertheim G, Speck NA, Tong W, Viatour P.

J Exp Med. 2017 Jul 3;214(7):1901-1912. doi: 10.1084/jem.20160719. Epub 2017 May 26.

4.

Recruitment of Pontin/Reptin by E2f1 amplifies E2f transcriptional response during cancer progression.

Tarangelo A, Lo N, Teng R, Kim E, Le L, Watson D, Furth EE, Raman P, Ehmer U, Viatour P.

Nat Commun. 2015 Dec 7;6:10028. doi: 10.1038/ncomms10028.

5.

In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer.

Santos M, Martínez-Fernández M, Dueñas M, García-Escudero R, Alfaya B, Villacampa F, Saiz-Ladera C, Costa C, Oteo M, Duarte J, Martínez V, Gómez-Rodriguez MJ, Martín ML, Fernández M, Viatour P, Morcillo MA, Sage J, Castellano D, Rodriguez-Peralto JL, de la Rosa F, Paramio JM.

Cancer Res. 2014 Nov 15;74(22):6565-6577. doi: 10.1158/0008-5472.CAN-14-1218. Epub 2014 Sep 24.

6.

Inactivation of the RB family prevents thymus involution and promotes thymic function by direct control of Foxn1 expression.

Garfin PM, Min D, Bryson JL, Serwold T, Edris B, Blackburn CC, Richie ER, Weinberg KI, Manley NR, Sage J, Viatour P.

J Exp Med. 2013 Jun 3;210(6):1087-97. doi: 10.1084/jem.20121716. Epub 2013 May 13.

7.

Bridges between Cell Cycle Regulation and Self-Renewal Maintenance.

Viatour P.

Genes Cancer. 2012 Nov;3(11-12):670-7. doi: 10.1177/1947601913481355.

8.

Newly identified aspects of tumor suppression by RB.

Viatour P, Sage J.

Dis Model Mech. 2011 Sep;4(5):581-5. doi: 10.1242/dmm.008060. Review.

9.

Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway.

Viatour P, Ehmer U, Saddic LA, Dorrell C, Andersen JB, Lin C, Zmoos AF, Mazur PK, Schaffer BE, Ostermeier A, Vogel H, Sylvester KG, Thorgeirsson SS, Grompe M, Sage J.

J Exp Med. 2011 Sep 26;208(10):1963-76. doi: 10.1084/jem.20110198. Epub 2011 Aug 29.

10.

MicroRNA programs in normal and aberrant stem and progenitor cells.

Arnold CP, Tan R, Zhou B, Yue SB, Schaffert S, Biggs JR, Doyonnas R, Lo MC, Perry JM, Renault VM, Sacco A, Somervaille T, Viatour P, Brunet A, Cleary ML, Li L, Sage J, Zhang DE, Blau HM, Chen C, Chen CZ.

Genome Res. 2011 May;21(5):798-810. doi: 10.1101/gr.111385.110. Epub 2011 Mar 30.

11.

G1 arrest and differentiation can occur independently of Rb family function.

Wirt SE, Adler AS, Gebala V, Weimann JM, Schaffer BE, Saddic LA, Viatour P, Vogel H, Chang HY, Meissner A, Sage J.

J Cell Biol. 2010 Nov 15;191(4):809-25. doi: 10.1083/jcb.201003048. Epub 2010 Nov 8.

12.

BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1.

Keutgens A, Zhang X, Shostak K, Robert I, Olivier S, Vanderplasschen A, Chapelle JP, Viatour P, Merville MP, Bex F, Gothot A, Chariot A.

J Biol Chem. 2010 Aug 13;285(33):25831-40. doi: 10.1074/jbc.M110.112128. Epub 2010 Jun 17.

13.

The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1.

Keutgens A, Shostak K, Close P, Zhang X, Hennuy B, Aussems M, Chapelle JP, Viatour P, Gothot A, Fillet M, Chariot A.

Mol Cell Biol. 2010 Aug;30(16):4006-21. doi: 10.1128/MCB.01600-09. Epub 2010 Jun 14.

14.

Regulation of RB transcription in vivo by RB family members.

Burkhart DL, Ngai LK, Roake CM, Viatour P, Thangavel C, Ho VM, Knudsen ES, Sage J.

Mol Cell Biol. 2010 Apr;30(7):1729-45. doi: 10.1128/MCB.00952-09. Epub 2010 Jan 25.

15.

Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexes.

Robert I, Aussems M, Keutgens A, Zhang X, Hennuy B, Viatour P, Vanstraelen G, Merville MP, Chapelle JP, de Leval L, Lambert F, Dejardin E, Gothot A, Chariot A.

Oncogene. 2009 Apr 2;28(13):1626-38. doi: 10.1038/onc.2009.6. Epub 2009 Feb 16.

16.

Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family.

Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL, Butte AJ, Passegué E, Sage J.

Cell Stem Cell. 2008 Oct 9;3(4):416-28. doi: 10.1016/j.stem.2008.07.009.

17.

GFP reporter mice for the retinoblastoma-related cell cycle regulator p107.

Burkhart DL, Viatour P, Ho VM, Sage J.

Cell Cycle. 2008 Aug 15;7(16):2544-52. Epub 2008 Aug 12.

18.
19.

Deregulated NF-kappaB activity in haematological malignancies.

Keutgens A, Robert I, Viatour P, Chariot A.

Biochem Pharmacol. 2006 Oct 30;72(9):1069-80. Epub 2006 Jul 18. Review.

PMID:
16854381
20.

Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.

Viatour P, Merville MP, Bours V, Chariot A.

Trends Biochem Sci. 2005 Jan;30(1):43-52. Review.

21.

Protein phosphorylation as a key mechanism for the regulation of BCL-3 activity.

Viatour P, Merville MP, Bours V, Chariot A.

Cell Cycle. 2004 Dec;3(12):1498-501. Epub 2004 Dec 22.

22.

GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity.

Viatour P, Dejardin E, Warnier M, Lair F, Claudio E, Bureau F, Marine JC, Merville MP, Maurer U, Green D, Piette J, Siebenlist U, Bours V, Chariot A.

Mol Cell. 2004 Oct 8;16(1):35-45.

23.

Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3.

Viatour P, Legrand-Poels S, van Lint C, Warnier M, Merville MP, Gielen J, Piette J, Bours V, Chariot A.

J Biol Chem. 2003 Nov 21;278(47):46541-8. Epub 2003 Sep 12.

24.

NF- kappa B2/p100 induces Bcl-2 expression.

Viatour P, Bentires-Alj M, Chariot A, Deregowski V, de Leval L, Merville MP, Bours V.

Leukemia. 2003 Jul;17(7):1349-56.

25.

Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines.

Bentires-Alj M, Dejardin E, Viatour P, Van Lint C, Froesch B, Reed JC, Merville MP, Bours V.

Oncogene. 2001 May 17;20(22):2805-13.

26.

Nuclear factor-kappa B, cancer, and apoptosis.

Bours V, Bentires-Alj M, Hellin AC, Viatour P, Robe P, Delhalle S, Benoit V, Merville MP.

Biochem Pharmacol. 2000 Oct 15;60(8):1085-9. Review.

PMID:
11007945

Supplemental Content

Loading ...
Support Center